Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes

De Ziegler, D.; Gayet, V.; Aubriot, F.ço.X.; Fauque, P.; Streuli, I.; Wolf, J.P.; de Mouzon, J.; Chapron, C.; De Ziegler, D; Gayet, V; Aubriot, F.ço.X; Fauque, P; Streuli, I; Wolf, J.P; de Mouzon, J; Chapron, C

doi:10.1016/j.fertnstert.2010.05.056

Home

>

Node

>

Subnode

Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes

De Ziegler, D.; Gayet, V.; Aubriot, F.ço.X.; Fauque, P.; Streuli, I.; Wolf, J.P.; de Mouzon, J.; Chapron, C.

Fertility and Sterility 94(7): 2796-2799

2010

ISSN/ISBN: 1556-5653

PMID: 20663495

DOI: 10.1016/j.fertnstert.2010.05.056

Document Number: 211550

In women with endometriosis, including those with endometriomas, 6 to 8 weeks of continuous use of oral contraception (OC) before assisted reproduction treatment (ART) maintains ART outcomes comparable with the outcomes of age-matched controls without endometriosis. In contrast, ART outcomes are markedly compromised in endometriosis patients who are not pretreated with OC. Ovarian responsiveness to stimulation was not altered by 6 to 8 weeks' use of pre-ART OC, including in poor responders with endometriomas.